Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Change in Cash (2016 - 2025)

Historic Change in Cash for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to -$10.6 million.

  • Anterix's Change in Cash rose 2603.96% to -$10.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 million, marking a year-over-year increase of 10440.49%. This contributed to the annual value of -$13.1 million for FY2025, which is 15252.19% down from last year.
  • Anterix's Change in Cash amounted to -$10.6 million in Q4 2025, which was up 2603.96% from -$107000.0 recorded in Q3 2025.
  • Anterix's Change in Cash's 5-year high stood at $26.9 million during Q4 2021, with a 5-year trough of -$22.1 million in Q1 2022.
  • Its 5-year average for Change in Cash is -$3.5 million, with a median of -$8.7 million in 2024.
  • In the last 5 years, Anterix's Change in Cash crashed by 34458.68% in 2022 and then soared by 140406.73% in 2025.
  • Quarter analysis of 5 years shows Anterix's Change in Cash stood at $26.9 million in 2021, then plummeted by 146.86% to -$12.6 million in 2022, then surged by 266.75% to $21.0 million in 2023, then crashed by 168.09% to -$14.3 million in 2024, then rose by 26.04% to -$10.6 million in 2025.
  • Its Change in Cash stands at -$10.6 million for Q4 2025, versus -$107000.0 for Q3 2025 and -$6.4 million for Q2 2025.